Repositioning HDAC inhibitors for glioma treatment: synthesis and biological evaluation (2026)
- Authors:
- Furtado, Luciana Costa
- Waitman, Karoline de Barros
- Silva, Nuno Albuquerque Tavares Ferreira da
- Gouvea, Leticia Marcelino
- Kronenberger, Thales
- Toledo, Mônica Franco Zannini Junqueira
- Ferreira, Elthon Gois
- Machado Neto, João Agostinho
- Kruyt, Frank A. E.
- Parise Filho, Roberto
- Costa-Lotufo, Letícia Veras
- Furtado, Luciana Costa
- USP affiliated authors: TOLEDO, MONICA FRANCO ZANNINI JUNQUEIRA - FCF ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; PARISE FILHO, ROBERTO - FCF ; LOTUFO, LETICIA VERAS COSTA - ICB ; GOUVEA, LETICIA MARCELINO - ICB ; FURTADO, LUCIANA COSTA - ICB ; WAITMAN, KAROLINE DE BARROS - FCF ; SILVA, NUNO ALBUQUERQUE TAVARES FERREIRA DA - FCF ; FERREIRA, ELTHON GOIS - ICB
- Unidades: FCF; ICB
- DOI: 10.1021/acsomega.5c11083
- Assunto: FARMACOLOGIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2026
- Source:
- Título: ACS Omega
- ISSN: 10104-10120
- Volume/Número/Paginação/Ano: v. 11, p. 10104-10120, 2026
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
FURTADO, Luciana Costa et al. Repositioning HDAC inhibitors for glioma treatment: synthesis and biological evaluation. ACS Omega, v. 11, p. 10104-10120, 2026Tradução . . Disponível em: https://doi.org/10.1021/acsomega.5c11083. Acesso em: 17 mar. 2026. -
APA
Furtado, L. C., Waitman, K. de B., Silva, N. A. T. F. da, Gouvea, L. M., Kronenberger, T., Toledo, M. F. Z. J., et al. (2026). Repositioning HDAC inhibitors for glioma treatment: synthesis and biological evaluation. ACS Omega, 11, 10104-10120. doi:10.1021/acsomega.5c11083 -
NLM
Furtado LC, Waitman K de B, Silva NATF da, Gouvea LM, Kronenberger T, Toledo MFZJ, Ferreira EG, Machado Neto JA, Kruyt FAE, Parise Filho R, Costa-Lotufo LV. Repositioning HDAC inhibitors for glioma treatment: synthesis and biological evaluation [Internet]. ACS Omega. 2026 ; 11 10104-10120.[citado 2026 mar. 17 ] Available from: https://doi.org/10.1021/acsomega.5c11083 -
Vancouver
Furtado LC, Waitman K de B, Silva NATF da, Gouvea LM, Kronenberger T, Toledo MFZJ, Ferreira EG, Machado Neto JA, Kruyt FAE, Parise Filho R, Costa-Lotufo LV. Repositioning HDAC inhibitors for glioma treatment: synthesis and biological evaluation [Internet]. ACS Omega. 2026 ; 11 10104-10120.[citado 2026 mar. 17 ] Available from: https://doi.org/10.1021/acsomega.5c11083 - Synthesis and biological evaluation of purine-benzohydroxamates as potential inhibitors of PI3K and HDAC6 for the treatment of hematologic malignancies
- Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- Dona Flor and her two husbands: discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment
- A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells
- Efficient synthesis of 6-Arylaminoflavones via buchwald-hartwig amination and its anti-tumor Investigation
- Synthesis and biological evaluation of hybrid inhibitors for the treatment of hematologic malignancies
- Purino-benzo-hidroxamatos contendo warhead de acrilamida: síntese e avaliação biológica de inibidores covalentes visando ao tratamento de neoplasias hematológicas
- Synthesis of 6-arylaminoflavones via buchwald–hartwig amination and Its anti-tumor investigation
- New kinase and HDAC hybrid inhibitors: recent advances and perspectives
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
